Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvalent, Inc.

61.99
-2.7100-4.19%
Post-market: 61.990.00000.00%16:07 EDT
Volume:932.75K
Turnover:56.93M
Market Cap:4.44B
PE:-15.79
High:65.88
Open:63.32
Low:58.05
Close:64.70
Loading ...

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Brainstorm Cell Therapeutics (BCLI)

TIPRANKS
·
Yesterday

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now?

Insider Monkey
·
01 Apr

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

PR Newswire
·
01 Apr

Optimistic Outlook on Nuvalent’s Zidesaminib: Promising Phase 1 Results and Strategic Positioning in ROS1-Positive NSCLC Market

TIPRANKS
·
31 Mar

Nuvalent Raised to Buy From Neutral by UBS

Dow Jones
·
14 Mar

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target

MT Newswires Live
·
14 Mar

Nuvalent’s Promising Oncology Position and Strategic Differentiation Justify Buy Rating

TIPRANKS
·
04 Mar

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Simply Wall St.
·
03 Mar

Nuvalent Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Mar

Barclays Remains a Buy on Nuvalent (NUVL)

TIPRANKS
·
28 Feb

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

Nuvalent, Inc. Reports 2024 Financial Results and Pipeline Progress

TIPRANKS
·
28 Feb

Earnings Flash (NUVL) Nuvalent Posts Q4 Net Loss $1.05 a Share, vs. FactSet Est of $1.08 Loss

MT Newswires Live
·
27 Feb

Nuvalent reports Q4 EPS ($1.05), consensus ($1.05)

TIPRANKS
·
27 Feb

Nuvalent Q4 2024 GAAP EPS $(1.05) Beats $(1.08) Estimate

Benzinga
·
27 Feb

Nuvalent Q4 Net Income USD -74.763 Million

THOMSON REUTERS
·
27 Feb

Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
27 Feb

Why Insiders Are Selling Nuvalent, Inc. (NUVL) Recently

Insider Monkey
·
12 Feb

Nuvalent (NASDAQ:NUVL) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
06 Feb